According to FutureWise analysis the market for antibody drug conjugate in 2023 is US$ 10.50 billion, and is expected to reach US$ around 26.68 billion by 2031 at a CAGR of 16.6%.
Antibody-drug conjugates (ADCs) are highly targeted biopharmaceutical medications that combine monoclonal antibodies to recognize surface antigens-specific tumor cells with highly potent anti-cancer agents linked via a chemical linker. Antibody-drug conjugates are complex molecules that require careful attention to various components. The selection of an appropriate target, a mAb, cytotoxic payload, and how the antibody is linked to the load are critical determinants of the safety and effectiveness of ADCs. These targeted agents combine antibodies' unique and very sensitive targeting capabilities, allowing acute discrimination between healthy and cancerous tissues with the cell-killing ability of cytotoxic drugs.
Antibodies are glycoproteins generated by the body in response to foreign particles. A monoclonal antibody (mAb) is made by cloning a specific WBC or unique parent cell. Monoclonal antibodies have monovalent affinity, which means they bind to a specific molecular region or part of an antigen known as an epitope or antigenic determinant. Polyclonal antibodies bind to different epitopes produced by various antibody cell lineages. There are five higher animal types of immunoglobulins: IgG, IgM, IgA, IgE, and IgD. IgG is the most prevalent of all. Each IgG molecule consists of four polypeptide chains, including two heavy chains of 50 kDa and two light chains of 25 kDa, held together by four disulfide bridges.
FutureWise Market Research has published a report that provides an insightful analysis antibody drug conjugate market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, antibody drug conjugate market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.